Rapid N-acetyltransferase 2 imputed phenotype and smoking may increase risk of colorectal cancer in women (Netherlands)

被引:23
作者
Olga L. van der Hel
H. Bas Bueno de Mesquita
Lodewijk Sandkuijl
Paul A.H. van Noord
Peter L. Pearson
Diederick E. Grobbee
Petra H.M. Peeters
机构
[1] Julius Ctr. Hlth. Sci./Prim. Care, University Medical Centre, Utrecht
[2] Dept. of Chron. Dis. Epidemiology, Natl. Inst. Pub. Hlth./Environ.
[3] Department of Medical Genetics, University Medical Centre, Utrecht
[4] Julius Ctr. Hlth. Sci./Prim. Care, University Medical Centre, 3508 GA Utrecht
关键词
Colorectal cancer; N-acetyltransferase; 2; Prospective study; Smoking; Women;
D O I
10.1023/A:1023601922106
中图分类号
学科分类号
摘要
Objective: The relationship between smoking and colorectal cancer risk and whether such effect is modified by variations in the NAT2 genotype is investigated. Methods: In the prospective DOM (Diagnostisch Onderzoek Mammacarcinoom; 27,722 women) cohort follow-up from 1976 until 1987 revealed 54 deaths due to colon or rectal cancer, and follow-up from 1987 to 01-01-1996 revealed 204 incident colorectal cancer cases. A random sample (n = 857) from the baseline cohort was used as controls. Four NAT2 restriction fragment length polymorphisms (RFLPs) were analysed using DNA extracted from urine samples. Rapid or slow acetylator phenotype status was attributed to individuals. Results: Smoking may increase the risk for colon cancer (RR = 1.36, 95% CI 0.97-1.92) as well as for rectal cancer (RR = 1.31, 95% CI 0.76-2.25), although not statistically significant. Rapid NAT2 acetylation did not increase colorectal cancer risk, but in combination with smoking the risk was statistically significant increased, compared to women who had a slow NAT2 imputed phenotype and never smoked (RR = 1.56, 95% CI 1.03-2.37). For colon cancer, but not for rectal cancer the increased risk was statistically significant (RR = 1.67, 95% CI, 1.05-2.67 versus RR = 1.30 95% CI 0.63-2.68). Conclusions: Our study points to smoking as a risk factor for colon and rectal cancer and, in addition, especially in women with rapid NAT2 imputed phenotype.
引用
收藏
页码:293 / 298
页数:5
相关论文
共 21 条
[1]  
Boyle P., Langman J.S., Epidemiology, BMJ, 321, pp. 805-808, (2000)
[2]  
Giovannucci E., An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 10, pp. 725-731, (2001)
[3]  
Wohlleb J.C., Hunter C.F., Blass B., Kadlubar F.F., Chu D.Z., Lang N.P., Aromatic amine acetyltransferase as a marker for colorectal cancer: Environmental and demographic associations, Int J Cancer, 46, pp. 22-30, (1990)
[4]  
Layton D.W., Bogen K.T., Knize M.G., Hatch F.T., Johnson V.M., Felton J.S., Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research, Carcinogenesis, 16, pp. 39-52, (1995)
[5]  
Gross M., Kruisselbrink T., Anderson K., Et al., Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population, Cancer Epidemiol Biomarkers Prev, 8, pp. 683-692, (1999)
[6]  
Brockton N., Little J., Sharp L., Cotton S.C., N-acetyltransferase polymorphisms and colorectal cancer: A HuGE review, Am J Epidemiol, 151, pp. 846-861, (2000)
[7]  
Giovannucci E., Colditz G.A., Stampfer M.J., Et al., A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women, J Natl Cancer Inst, 86, pp. 192-199, (1994)
[8]  
De Waard F., Collette H.J., Rombach J.J., Baanders-Van Halewijn E.A., Honing C., The DOM project for the early detection of breast cancer, Utrecht, The Netherlands, J Chronic Dis, 37, pp. 1-44, (1984)
[9]  
Van Der Hel O.L., Van Der Luijt R.B., Bas Bueno D.M., Et al., Quality and quantity of DNA isolated from frozen urine in population-based research, Anal Biochem, 304, pp. 206-211, (2002)
[10]  
Van Duijnhoven F.J.B., Van Der Hel O.L., Van Der Luijt R.B., Bueno De Mesquita H.B., Van Noord P.A., Peeters P.H.M., Quality of NAT2 genotyping with Restriction Fragment Length Polymorphism using DNA isolated from frozen urine, Cancer Epidemiol Biomarkers Prev, 11, pp. 771-776, (2002)